Candidates
Vaccines
- Phase 1: 32 Vaccines
- Phase 2: 44 Vaccines
- Phase 3: 33 Vaccines
- Approved: 14 Vaccines
Last Updated 5 May 2021.
14 Vaccines Approved by at Least One Country
-
Anhui Zhifei Longcom
RBD-Dimer- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
6 trials in 5 countries
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 9 countries
5 trials in 1 country
-
CanSino
Ad5-nCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 5 countries
8 trials in 6 countries
-
Chumakov Center
KoviVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
FBRI
EpiVacCorona- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
3 trials in 1 country
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 65 countries
19 trials in 6 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 41 countries
8 trials in 17 countries
-
Moderna
mRNA-1273- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 45 countries
17 trials in 3 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 98 countries
25 trials in 15 countries
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 84 countries
18 trials in 12 countries
-
Serum Institute of India
Covishield- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
2 trials in 1 country
-
Sinopharm (Beijing)
BBIBP-CorV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
6 trials in 7 countries
-
Sinopharm (Wuhan)
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
6 trials in 7 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 24 countries
14 trials in 7 countries
33 Vaccines in Phase 3 Clinical Trials
-
Instituto Finlay de Vacunas Cuba
FINLAY-FR-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 1 country
-
Sanofi/GSK
Recombinant Protein- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 2 countries
-
Novavax
NVX-CoV2373- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 6 countries
-
Center for Genetic Engineering and Biotechnology (CIGB)
CIGB-66- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 1 country
-
Anhui Zhifei Longcom
RBD-Dimer- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
6 trials in 5 countries
-
Clover
SCB-2019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 10 countries
-
COVAXX
UB-612- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Instituto Finlay de Vacunas Cuba
FINLAY-FR-2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 1 country
-
FBRI
EpiVacCorona- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
3 trials in 1 country
-
Medicago
Plant-based VLP- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 2 countries
-
AnGes
AG0302-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Inovio
INO-4800- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 3 countries
-
Zydus Cadila
ZyCoV-D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 1 country
-
Curevac
CVnCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
10 trials in 11 countries
-
Moderna
mRNA-1273- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 45 countries
17 trials in 3 countries
-
Walvax
mRNA- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Pfizer/BioNTech
BNT162b1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 3 countries
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 84 countries
18 trials in 12 countries
-
CanSino
Ad5-nCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 5 countries
8 trials in 6 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 98 countries
25 trials in 15 countries
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 65 countries
19 trials in 6 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 41 countries
8 trials in 17 countries
-
Serum Institute of India
Covishield- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
2 trials in 1 country
-
ReiThera
GRAd-COV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 12 countries
-
Minhai Biotechnology Co
SARS-CoV-2 Vaccine (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 1 country
-
Chinese Academy of Medical Sciences
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 3 countries
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 9 countries
5 trials in 1 country
-
Shifa Pharmed Industrial Co
COVID-19 Inactivated Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Sinopharm (Beijing)
BBIBP-CorV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
6 trials in 7 countries
-
Sinopharm (Wuhan)
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
6 trials in 7 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 24 countries
14 trials in 7 countries
-
Valneva
VLA2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 1 country
-
Kazakhstan RIBSP
QazCovid-in- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 1 country
44 Vaccines in Phase 2 Clinical Trials
-
West China Hospital
Recombinant (Sf9 cell)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 1 country
-
EuBiologics Co Ltd
EuCorVac-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
University of Saskatchewan
COVAC-2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
University Medical Center Groningen
AKS-452- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Takeda
TAK-019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
SK Bioscience Co Ltd
GBP510- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 1 country
-
Shionogi
S-268019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Razi Vaccine and Serum Research Institute
Razi Cov Pars- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
National Vaccine and Serum Institute
Recombinant SARS-CoV-2 Vaccine (CHO Cell)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Nanogen
Nanocovax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Medigen
MVC-COV1901- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 2 countries
-
Kentucky Bioprocessing
KBP-201- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Livzon Mabpharm Inc
V-01- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Biological E Limited
BECOV2B- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
0 trials in 1 country
-
Biological E Limited
BECOV2A- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Biological E Limited
BECOV2C- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
0 trials in 1 country
-
Center for Genetic Engineering and Biotechnology (CIGB)
CIGB-669- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Biological E Limited
BECOV2D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
VBI Vaccines Inc
VBI-2902a- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
SpyBiotech
RBD SARS-CoV-2 HBsAg VLP- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Entos Pharmaceuticals Inc
Covigenix VAX-001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
GeneOne Life Science Inc
GLS-5310- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Genexine
GX-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 1 country
-
Takis
COVID-eVax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
AnGes
AG0301-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Sanofi Pasteur
MRT5500- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Arcturus Therapeutics Inc
LUNAR-COV19/ARCT-021- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 2 countries
-
Takeda
TAK-919- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Pfizer/BioNTech
BNT162b3- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Pfizer/BioNTech
BNT162c2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Elixirgen Therapeutics Inc
EXG-5003- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Pfizer/BioNTech
BNT162a1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Chulalongkorn University
ChulaCov19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Daiichi Sankyo Co Ltd
DS-5670a- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Shenzhen Geno-Immune Medical Institute
LV-SMENP- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Institute of Vaccines and Medical Biologicals
COVIVAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
ImmunityBio Inc
hAd5-Covid-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
7 trials in 2 countries
-
Cellid Co
AdCLD-CoV19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Mahidol University
NDV-HXP-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Israel Institute for Biological Research (IIBR)
IIBR-100- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Wantai
DelNS1-2019-nCoV-RBD-OPT- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Aivita Biomedical Inc
AV-COVID-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 2 countries
-
Chumakov Center
KoviVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
Health Institutes of Turkey
ERUCOV-VAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
32 Vaccines in Phase 1 Clinical Trials
-
Adimmune Corporation
AdimrSC-2f- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Meissa Vaccines Inc
MV-014-212- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
US Army Medical Research and Development Command
SpFN COVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Tuebingen
CoVac-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
The University of Hong Kong
DelNS1-nCoV-RBD LAIV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
SK Bioscience Co Ltd
NBP2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Vaxine
COVAX-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Jiangsu Rec-Biotechnology Co Ltd
ReCOV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Codagenix Inc
COVI-VAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
The Scientific and Technological Research Council of Turkey
SARS-CoV-2 VLP Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Radboud University
ABNCoV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Providence Health & Services
CORVax12- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
University of Sydney
COVIGEN- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Symvivo
bacTRL-Spike- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
SENAI CIMATEC
HDT-301- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 0 countries
-
Providence Therapeutics Holdings Inc
PTX-COVID19-B- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Moderna
mRNA-1273.351- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Moderna
mRNA-1283- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
GlaxoSmithKline
CoV2 SAM (LNP)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Altimmune Inc
AdCOVID- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
NIAID
SAM-LNP-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
NIAID
ChAdV68-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Tetherex Pharmaceuticals Corporation
SC-Ad6-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Bharat Biotech
BBV154- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Universitatsklinikum Hamburg-Eppendorf
MVA-SARS-2-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
AMMS
Ad5-nCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Vaxart
VXA-CoV2-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
City of Hope Medical Center
COH04S1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Shenzhen Geno-Immune Medical Institute
Covid-19/aAPC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Organization of Defensive Innovation and Research
FAKHRAVAC (MIVAC)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Kocak Farma
Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
The Scientific and Technological Research Council of Turkey
Adjuvanted Inactivated Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
5 Vaccines are No Longer Progressing
-
Merck Sharp & Dohme Corp
V591- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 3 countries
-
Imperial
LNP-nCoVsaRNA- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Institut Pasteur
COVID-19-101- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 2 countries
-
Merck Sharp & Dohme Corp
V590- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Queensland
Sclamp- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country